Urtasun, A.; Olivera, G.G.; Sendra, L.; Aliño, S.F.; Berlanga, P.; Gargallo, P.; Hervás, D.; Balaguer, J.; Juan-Ribelles, A.; Andrés, M.d.M.;
et al. Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy. Cancers 2023, 15, 1424.
https://doi.org/10.3390/cancers15051424
AMA Style
Urtasun A, Olivera GG, Sendra L, Aliño SF, Berlanga P, Gargallo P, Hervás D, Balaguer J, Juan-Ribelles A, Andrés MdM,
et al. Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy. Cancers. 2023; 15(5):1424.
https://doi.org/10.3390/cancers15051424
Chicago/Turabian Style
Urtasun, Andrea, Gladys G. Olivera, Luis Sendra, Salvador F. Aliño, Pablo Berlanga, Pablo Gargallo, David Hervás, Julia Balaguer, Antonio Juan-Ribelles, MarÃa del Mar Andrés,
and et al. 2023. "Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy" Cancers 15, no. 5: 1424.
https://doi.org/10.3390/cancers15051424
APA Style
Urtasun, A., Olivera, G. G., Sendra, L., Aliño, S. F., Berlanga, P., Gargallo, P., Hervás, D., Balaguer, J., Juan-Ribelles, A., Andrés, M. d. M., Cañete, A., & Herrero, M. J.
(2023). Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy. Cancers, 15(5), 1424.
https://doi.org/10.3390/cancers15051424